Pain medicine : the official journal of the American Academy of Pain Medicine
-
Clinical Trial
Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.
To assess the efficacy and safety of palmitoylethanolamide (PEA), an endogenous fatty acid amide belonging to the N-acylethanolamines family, in reducing pain severity in patients with pain associated to different pathological conditions. ⋯ In this study, PEA was effective and safe in the management of chronic pain in different pathological conditions.
-
The objective of this study was to use administrative claims data to identify and analyze patient characteristics and behavior associated with diagnosed opioid abuse. ⋯ Using medical as well as drug claims data, it is feasible to develop models that could assist payers in identifying patients who exhibit characteristics associated with increased risk for opioid abuse. These models incorporate medical information beyond that available to prescription drug monitoring programs that are reliant on drug claims data and can be an important tool to identify potentially inappropriate opioid use.